Stock Market Damage Has Been Done, New Trades

In This Edition....

Market Update: The Damage Has Been Done
From the Community
New Trades: Amylin Pharmaceuticals (AMLN), WMS Industries (WMS)

Market Update: The Damage Has Been Done

Stocks are back in the black today after a very tough start to the week, but is the rally too little, too late? We believe it is, though we don't necessarily feel it's the end of the world for investors.

We'll detail the idea below, but we first want to let you know where the analysis is going... the market is due (overdue, actually) for a normal corrective action. September is a losing month - on average - for stocks anyway, so it makes sense the corrective move is playing out now.

OK, with that on the table, here's what we're seeing...

Before jumping to any bullish conclusions about today's modest gains, we'll remind you if you drop anything from high enough, it'll bounce. And, stocks certainly fell a great distance yesterday. That's why we're not going to focus too much on today's action, and instead will highlight the fact that August's anemic bullish streak has been broken thanks to losses on Monday and Tuesday.

The problem is, we've seen these stumbles before over the last six month, yet none of them really took hold in a meaningful way. What makes this one different?

As it turns out, the "What makes this one different?" question wasn't just rhetorical.... this one really is different. The prior ones we're never really interpreted as a serious threat to the uptrend... this dip has actually spooked people. And, if investors are truly fearful, they're going to behave accordingly.

The evidence of this fear comes in the form of the VIX... the CBOE's 'fear gauge'. The higher it rises, the more afraid investors are. As you might imagine, it's been falling since March while stocks rallied and confidence grew, and even continued to fall when the market was temporarily tripped up in May and July. Over the last two weeks though, the VIX has clearly changed direction - upward.

It's not terribly evident on a daily chart, but when you take a look at the weekly chart (for the VIX as well as the broad market) it's pretty clear something's different. The VIX has handed us a rising MACD cross... the first in almost a year.

So how far is the market going to fall? That's the good news. If it does indeed pull back, it doesn't really need to retreat all that much to humble the bulls. All it really needs to do is slide back far enough to convince most investors the bull market is already over. Once the majority is convinced they need to be out of the market, I expect the bull trend to resume. That will also coincide with the norm of hitting lows in September, and then starting a major Q4 rally in October.

To be specific though, I think the S&P 500 will need to move all the way back to somewhere between 800 and 900. The lower level is about a 61.8% Fibonacci retracement, while the upper level is roughly a 38.2% Fibonacci retracement (sorry, neither is shown on the chart... not enough room). Hitting either level would mean quite a dip, but remember - the selloff has to be big enough to burn off all the euphoria before the bulls can reload.

As always, this analysis is not static but ongoing. Stay tuned.

From the Community

Here's what you missed from our community commentary if you're not visiting the site every day:

New Trading Ideas

We don't have any updates on open trades for you today, but we do have two new trading ideas to issue.

Amylin Pharmaceuticals, Inc. (AMLN) - long/bullish

Though the market may be headed into the red for the next few weeks, if there's any group that can buck that trend, it's biotech. Amylin Pharmaceuticals looks like it could be one of the better stocks from the group.

There are two things working in Amylin's favor here. The first one is chart timing - AMLN shares have just encountered an intermediate-term support line, and so far seem to have halted their downtrend there. That's the first step in making an upside reversal. And, given that the selling volume was never all that heavy on the way down, we don't expect much in the way of a headwind if the stock does end up moving higher like we think it will.

The other factor helping AMLN shares now is a little more esoteric.

Amylin's relationship with Lilly (they're partners in a diabetes drug enterprise) has historically been an amicable one, though there have been lingering whispers that Lilly should just buy Amylin outright. It was just chatter though, until Carl Icahn was able to place representation on Amylin's board of directors. Given the billionaire's history and clout, one can't help but wonder if an acquisition of Amylin is in the cards. Of course, it would (hopefully) be at a premium price.

That's still way down the road if it happens at all, but the market is mulling it now.

WMS Industries Inc. (WMS) - short/bearish

It's not that WMS Industries is a bad company - it's just that the stock is so overextended right now, there's considerably more downside in the near future than potential upside.

WMS appears to have rolled over during the last week or so, after racing to a peak of $43.88. And, the 'down' has accelerated.

As for how low WMS Industries shares could go, that's a bit trickier. You could argue the gap at $35.89 (from August 4th) just needs to be closed, and then the stock can get going again. If that's the case, then WMS is only due for about a 13% dip. It's not a bad move, but there's bigger and better. [Note that options are available for WMS, so any pullback could be augmented by leveraging it with a put trade.] Or, you could also argue the April 21st gap at $26.95 needs to be closed as well; a pullback to that level is a much more enticing 35% possibility.

So, this is a bearish trade we're entering with short-term expectations, but cognizant of the fact it could turn into a longer-term and very profitable trade if things go well.

That's it for today; be sure to check the website for other updates.

Click Here to View the SmallCap Network Disclosure

Small Cap Stocks and Penny Stocks for Big Returns